- CNIO research on lung, skin and pancreatic cancer receives funding from the Spanish Association Against Cancer
18.02.2025
The search for new treatments against the most aggressive lung cancer, malignant melanoma and pancreatic cancer, the possibility of using nutrition against metastasis, the study of resistance to targeted therapies for melanoma, and the development of therapies based on tumor nutrients are projects at the Spanish National Cancer Research Center (CNIO) selected for the grants […] - CNIO researchers seek more effective immunotherapies for children with cancer
14.02.2025
Pediatric cancer is relatively rare, yet it is the leading cause of death by disease in children and teenagers in the developed world. It is different from adult cancer and therefore requires research and specific therapies. But for pediatric patients treatments are not improving at the same rate as for the rest, recalls Antonio Pérez-Martínez, […] - Female researchers at CNIO ‘talk’ to the girls they once were
11.02.2025
‘I know you have plenty of doubts’, ‘trust yourself’, ‘don’t worry if you are told to ask too many questions.’ Six female researchers who currently work at the main Spanish public center for cancer research, the National Cancer Research Centre (CNIO), recall the girls they once were in the hope to reach out to the […] - Meet in Instagram the youngest CNIO researchers
04.02.2025
On the occasion of World Cancer Day, a date that seeks to promote prevention, early detection and advances in treatment, in the next few hours we will connect with young researchers from each program of the Spanish National Cancer Research Center (CNIO). Throughout the day Pablo Blanco, from the Clinical Research Program; Guillermo Garaulet, from […] - Eva González Suárez will advance towards the development of new inhibitors against breast cancer with a new grant from the European Research Council
23.01.2025
Breast cancer is the most common disease among women in the Western world. It causes half a million deaths a year, mainly due to metastasis. Of the 300,000 women diagnosed with this disease each year, 15-20% are affected by triple-negative breast cancer. This subtype is characterized by a high recurrence rate, the propensity to form […] - CNIO research identifies a key protein for ‘burning’ fat
13.01.2025
Obesity, which affects 650 million people worldwide, influences the development of cardiometabolic diseases and increases the risk of cancer. Guadalupe Sabio, head of the Organ Crosstalk in Metabolic Diseases Group at the National Cancer Research Centre (CNIO), and Cintia Folgueira, from CNIO and the National Centre for Cardiovascular Research (CNIC), have discovered one of the […] - CNIO’s youngest researchers show their drive
07.01.2025
More than a hundred young people carry out their PhD research at the Spanish National Cancer Research Center (CNIO). They thus get in touch with frontline cancer research, while their curiosity, fresh perspectives and creativity contribute to maintaining the center’s level of excellence. Once a year they enjoy the opportunity to present the results of […] - L’Oréal Dermatological Beauty and CNIO renew their collaboration for skin cancer research
05.12.2024
The most frequent cancer type is skin cancer and its incidence is increasing worldwide. The study of its causes and development is essential to improve treatments. This is why La Roche-Posay, the dermatological laboratory of L’Oréal Dermatological Beauty, is collaborating since 2019 with the Spanish National Cancer Research Center (CNIO) to support research related to […] - CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive
29.11.2024
Ewing sarcoma is a tumour of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare – 9 to 10 cases per million inhabitants per year – but it is very aggressive. 25% of patients do not respond well to regular therapy and they often experience […]